Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Recruiting · NCT06999707 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-10-01 | NCT06999707 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chang Gung Memorial Hospital | 214 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Memorial Hospital at Linkou | Taoyuan City | Taiwan | 7 |